The Beauty Health Company (NASDAQ:SKIN) Shares Bought by SG Americas Securities LLC

SG Americas Securities LLC raised its holdings in The Beauty Health Company (NASDAQ:SKIN) by 35.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 39,630 shares of the company’s stock after acquiring an additional 10,332 shares during the period. SG Americas Securities LLC’s holdings in Beauty Health were worth $123,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Senvest Management LLC increased its holdings in shares of Beauty Health by 30.8% in the 3rd quarter. Senvest Management LLC now owns 8,937,381 shares of the company’s stock valued at $53,803,000 after purchasing an additional 2,106,622 shares during the period. Braidwell LP acquired a new position in shares of Beauty Health in the 3rd quarter valued at about $9,790,000. Norges Bank acquired a new position in shares of Beauty Health in the 4th quarter valued at about $7,730,000. Vanguard Group Inc. increased its holdings in shares of Beauty Health by 8.6% in the 3rd quarter. Vanguard Group Inc. now owns 10,514,288 shares of the company’s stock valued at $123,964,000 after purchasing an additional 830,141 shares during the period. Finally, ArrowMark Colorado Holdings LLC increased its holdings in shares of Beauty Health by 88.5% in the 4th quarter. ArrowMark Colorado Holdings LLC now owns 1,387,175 shares of the company’s stock valued at $12,623,000 after purchasing an additional 651,452 shares during the period. Institutional investors and hedge funds own 93.26% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on SKIN. Canaccord Genuity Group upped their target price on Beauty Health from $3.00 to $4.00 and gave the company a “hold” rating in a report on Thursday, March 14th. Stifel Nicolaus restated a “hold” rating and issued a $4.00 price objective (up previously from $3.00) on shares of Beauty Health in a report on Wednesday, March 13th. Piper Sandler restated an “underweight” rating and issued a $3.00 price objective (up previously from $2.00) on shares of Beauty Health in a report on Wednesday, March 13th. DA Davidson restated a “buy” rating and issued a $5.00 price objective on shares of Beauty Health in a report on Friday, March 15th. Finally, TD Cowen increased their price objective on Beauty Health from $2.50 to $4.00 and gave the stock a “market perform” rating in a report on Wednesday, March 13th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $6.50.

Beauty Health Stock Up 3.6 %

Shares of Beauty Health stock opened at $3.43 on Friday. The stock has a market capitalization of $423.36 million, a P/E ratio of -4.45 and a beta of 1.01. The company has a quick ratio of 5.28, a current ratio of 6.07 and a debt-to-equity ratio of 12.43. The stock has a 50 day moving average price of $3.64 and a two-hundred day moving average price of $3.51. The Beauty Health Company has a 12-month low of $1.35 and a 12-month high of $13.90.

Beauty Health (NASDAQ:SKIN) last announced its earnings results on Tuesday, March 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.04. The firm had revenue of $96.80 million during the quarter, compared to analysts’ expectations of $87.22 million. Beauty Health had a negative return on equity of 18.85% and a negative net margin of 25.65%. The company’s revenue was down 1.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.03 earnings per share. Equities analysts expect that The Beauty Health Company will post -0.1 earnings per share for the current year.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.